Pharmaceuticals News

Vancouver, British Columbia--(Newsfile Corp. - August 3, 2021) - BioCure Technology Inc. (CSE: CURE) (OTCQB: BICTF) (FSE: 1WH ) (CURE or the Company) - BioCure Technology Inc. ("BioCure" or the "Company") is pleased to announce listing on the Frankfurt Stock Exchange as of August 2, 2021 and the completion of...
Biotechnology, Pharmaceuticals, Health
2021-08-03 2:27 PM EDT | Biocure Technology Inc.

San Diego, California--(Newsfile Corp. - August 3, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp"), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs through accelerated regulatory pathways, announced today that it will present at the Canaccord Genuity Virtual Growth Conference.The conference will be...
Biotechnology, Pharmaceuticals
2021-08-03 7:05 AM EDT | Tryp Therapeutics Inc.

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 3, 2021) -  Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to issue an update on its cutting-edge pre-clinical studies and on the development progress of its Liposome/CBD delivery platform (LPT). These studies are led...
Pharmaceuticals, Cannabis, Cannabis Manufacturer, Cannabis Ancillary Service Provider
2021-08-03 2:53 AM EDT | Innocan Pharma Corporation

ANVS401's Interim Clinical Data Demonstrate Statistically Significant Improvements in Cognitive Function in AD Patients and Motor Function in PD PatientsBiomarkers Demonstrate Reduction in Neurotoxic Proteins, Improvement in Axonal Health and Reduction in Inflammation Levels Next Clinical Data Readout Expected in the Third Quarter Berwyn, Pennsylvania--(Newsfile Corp.
Biotechnology, Pharmaceuticals
2021-07-30 10:06 AM EDT | Annovis Bio, Inc.

Vancouver, British Columbia--(Newsfile Corp. - July 29, 2021) - LeanLife Health Inc. (CSE: LLP) (FSE: LL1) (OTCQB: LHLNF) (the "Company"), has entered into a 1 year marketing and consulting contract with Toronto-based marketing firm, North Equities Corp. (the "Contract"). North Equities Corp. ("North Equities" or "NE"), specializes in various...
Food/Beverages, Pharmaceuticals
2021-07-29 3:18 PM EDT | LeanLife Health Inc.

Ottawa, Ontario--(Newsfile Corp. - 29 juillet 2021) - Médicaments novateurs Canada (MNC) est la voix nationale de l'industrie pharmaceutique innovatrice canadienne. Nos membres produisent les vaccins, les diagnostics et les médicaments qui permettent à notre pays de se relever de la pandémie mondiale qui continue d'avoir des effets dévastateurs sur...
Healthcare and Hospitals, Pharmaceuticals
2021-07-29 11:09 AM EDT | Innovative Medicines Canada

Ottawa, Ontario--(Newsfile Corp. - July 29, 2021) - Innovative Medicines Canada (IMC) is the national voice for Canada's innovative pharmaceutical industry. Our members produce many of the vaccines, medicines, and diagnostics that are enabling Canada to emerge from the global pandemic that continues to have a devastating impact on the...
Healthcare and Hospitals, Pharmaceuticals
2021-07-29 11:06 AM EDT | Innovative Medicines Canada

Toronto, Ontario--(Newsfile Corp. - July 29, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc. ("ABcann"), today...
Pharmaceuticals, Cannabis, Health
2021-07-29 7:30 AM EDT | VIVO Cannabis Inc.

San Diego, California--(Newsfile Corp. - July 28, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs through accelerated regulatory pathways, announced today its interim financial results for the three and nine month period...
Biotechnology, Pharmaceuticals
2021-07-28 11:19 PM EDT | Tryp Therapeutics Inc.

Berwyn, Pennsylvania--(Newsfile Corp. - July 28, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative diseases, with data from two phase 2 studies showing its lead compound improves cognition in AD patients...
Biotechnology, Pharmaceuticals
2021-07-28 7:30 PM EDT | Annovis Bio, Inc.

Austin, Texas--(Newsfile Corp. - July 28, 2021) - On Thursday, July 29th, newly founded Digital Therapeutics company will be giving a presentation at Microdose's Psychedelic Capital Event. Presenting will be the two founding executives Robin Arnott (CEO) and Lyle Maxson (CSO)."Psychedelic Therapy is the most important movement in mental health...
Pharmaceuticals, Cannabis, Psychedelics, Cannabis Manufacturer
2021-07-28 4:13 PM EDT | Microdose Psychedelic Insights

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 28, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") filed a patent application for its topical composition for hair loss treatment. The patent application discloses and claims several compositions for topical administration comprising cannabinoid...
Pharmaceuticals, Cannabis, Cannabis Manufacturer, Cannabis Ancillary Service Provider
2021-07-28 4:00 PM EDT | Innocan Pharma Corporation

Jackson Center, Pennsylvania--(Newsfile Corp. - July 28, 2021) - Halberd Corporation (OTC Pink: HALB) establishes "proof of concept" taking a major step towards the elimination of multiple infectious diseases, such as, malaria, tuberculosis, sepsis, meningitis, and pandemics, among others, by successfully eliminating E. Coli bacteria through the use of its...
Biotechnology, Pharmaceuticals, Health
2021-07-28 8:00 AM EDT | Halberd Corp.

San Diego, California--(Newsfile Corp. - July 27, 2021) -  Mycrodose Therapeutics, a US-Based pharmaceutical company focused on developing advanced drug delivery systems for use with psychedelic compounds, announced today that its Executive team will be participating in the upcoming Psychedelic Capital Event on July 29, 2021. The virtual conference hosted by...
Pharmaceuticals, Cannabis, Psychedelics, Cannabis Manufacturer
2021-07-27 10:18 AM EDT | Microdose Psychedelic Insights

Vancouver, British Columbia--(Newsfile Corp. - July 27, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN), will report financial results for the second quarter ended June 30, 2021 on Tuesday, August 10 2021. Neovasc's President and Chief Executive Officer, Fred Colen, and Chris Clark, Chief Financial Officer, will host a conference...
Pharmaceuticals, Health
2021-07-27 9:05 AM EDT | Neovasc Inc.

Get a free ticket to the event here: https://microdose.buzz/nwdmtToronto, Ontario--(Newsfile Corp. - July 27, 2021) - Microdose in partnership with Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1), a biotechnology company focused on developing psychedelic medicines to treat addiction, Alge
Pharmaceuticals, Cannabis, Psychedelics, Cannabis Manufacturer
2021-07-27 7:00 AM EDT | Microdose Psychedelic Insights

San Diego, California--(Newsfile Corp. - July 26, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp"), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs through accelerated regulatory pathways, announced today the appointment of Robin Carhart-Harris, Ph.D. as Chairman of its Scientific Advisory Board ("SAB")...
Biotechnology, Pharmaceuticals
2021-07-26 9:43 AM EDT | Tryp Therapeutics Inc.

Vancouver, British Columbia--(Newsfile Corp. - July 23, 2021) -  Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald")  has retained BC Farm & Ranch Realty Corp., a real estate agent dedicated 100% to agricultural properties, to assist in the sale of its licensed greenhouse cannabis production facility in Greater Vancouver,...
Pharmaceuticals, Cannabis, Health, Cannabis Manufacturer
2021-07-23 4:47 PM EDT | Emerald Health Therapeutics, Inc.

Berwyn, Pennsylvania--(Newsfile Corp. - July 23, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative diseases, with data from two phase 2 studies showing its lead compound improves cognition in AD patients...
Biotechnology, Pharmaceuticals
2021-07-23 8:30 AM EDT | Annovis Bio, Inc.